Skip to main content
SpringerLink
Log in

Cancer Chemo- and Immunopharmacology

1. Chemopharmacology

  • Book
  • © 1980

Overview

Editors:
  1. Georges Mathé

    1. Institut de Cancérologie et Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Franco M. Muggia

    1. Medical Center, Division of Oncology, Department of Internal Medicine, Institute of Environmental Medicine, New York University, New York, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 74)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (38 chapters)

  1. Front Matter

    Pages I-XIII
    Download chapter PDF

  2. General Progress in Clinical Chemotherapy of Advanced Disease

    • F. M. Muggia, J. Henney, V. DeVita Jr.
    Pages 1-7

  3. Adjuvant Therapies of Postsurgical Minimal Residual Disease

    • G. Bonadonna, M. Gasparini, A. Rossi
    Pages 8-25

  4. Limits of Animal Models in Cancer Chemotherapy

    • S. Garattini
    Pages 26-30

  5. Clinical Chemotherapy: Its Correlation with Experimental Models

    • S. K. Carter
    Pages 31-36

  6. Metabolic Conversion of Methotrexate in Man

    • R. C. Donehower
    Pages 37-41

  7. Biochemical Control of High-Dose Methotrexate/Leucovorin Rescue Therapy

    • W. Wilmanns, H. Sauer, A. Schalhorn
    Pages 42-49

  8. High-Dose Methotrexate in Combination Chemotherapy for Small Cell Lung Cancer

    • F. A. Greco, K. R. Hande, R. L. Richardson, R. K. Oldham
    Pages 50-55

  9. Clinical and Laboratory Reevalution of Dichloromethotrexate

    • B. Fernbach, I. Takahashi, T. Ohnuma, J. F. Holland
    Pages 56-64

  10. An Overview of the Clinical Pharmacology of N-Phosphonacetyl-L-Aspartate (PALA), a New Antimetabolite

    • C. Erlichman
    Pages 65-71

  11. N-(Phosphonacetyl)-L-Aspartate (PALA): Current Status

    • M. Rozencweig, R. Abele, M. Piccart, D. D. Von Hoff, F. M. Muggia
    Pages 72-77

  12. Synthesis, Biologic Effects, and Biochemical Properties of Some 2’-Azido- and 2’-Amino-2’-Deoxyarabinofuranosyl Pyrimidines and Purines

    • M. Bobek, Y.-C. Cheng, E. Mihich, A. Bloch
    Pages 78-83

  13. Prediction of Clinical Response to 5-Fluorouracil-Containing Chemotherapy: Preliminary Results of in Vitro Assay in Human Breast Cancer

    • B. Ardalan, J. Macdonald, D. Cooney, M. Lippman, P. Schein
    Pages 84-90

  14. Vindesine: A New Vinca Alkaloid

    • M. Bayssas, J. Gouveia, F. de Vassal, J.-L. Misset, L. Schwarzenberg, P. Ribaud et al.
    Pages 91-97

  15. The Epipodophyllotoxin Derivatives VM-26 and VP-16-213, 1976–1979, a Review

    • N. I. Nissen, P. Dombernowsky, H. H. Hansen, A. G. Pedersen
    Pages 98-106

  16. Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)

    • C. Paoletti, J.-B. Le Pecq, N. Dat-Xuong, P. Juret, H. Garnier, J.-L. Amiel et al.
    Pages 107-123

  17. Comparative Pharmacokinetics of Chlorambucil and Melphalan in Man

    • D. S. Alberts, S. Y. Chang, H.-S. G. Chen, B. J. Larcom, T. L. Evans
    Pages 124-131

  18. Clinical Implications of Cisplatin Pharmacology

    • F. M. Muggia, M. Rozencweig, J. Penta
    Pages 132-138

  19. Cisplatinumdiamminodichloride (CPDD) in Chemotherapy of Cancers: A Phase II Therapeutic Trial

    • M. Hayat, G. Brulé, P. Cappelaere, A. Cattan, J. Chauvergne, B. Clavel et al.
    Pages 139-145

  20. 1,2-Diaminocyclohexane Platinum Derivatives of Potential Clinical Value

    • J. H. Burchenal, G. Irani, K. Kern, L. Lokys, J. Turkevich
    Pages 146-155
Back to top

Keywords

Editors and Affiliations

  • Institut de Cancérologie et Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    Georges Mathé

  • Medical Center, Division of Oncology, Department of Internal Medicine, Institute of Environmental Medicine, New York University, New York, USA

    Franco M. Muggia

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation